Bristol Myers Squibb Commits to Veeva Vault CRM

Go back to Bristol Myers Squibb Commits to Veeva Vault CRM

Stifel on Veeva Systems (VEEV): 'today's announcement is not incremental'

September 22, 2025 2:26 PM EDT

Stifel analyst David Grossman reiterated a Buy rating and $320.00 price target on Veeva Systems (NYSE: VEEV).

The analyst comments "This morning during market hours, Veeva announced that Bristol Myers Squibb (#8) has committed to Veeva Vault CRM. During Veeva's F2Q (July)... More